Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Auteur principal: | Tania, Umme |
---|---|
Autres auteurs: | Haque , Md. Aminul |
Format: | Thèse |
Langue: | en_US |
Publié: |
Brac University
2021
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/15111 |
Documents similaires
-
Biosimilar in lymphoma treatment
par: Tanisha, Mehrin Haque
Publié: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
par: Tabassum, Turana
Publié: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
par: Sagar, Baejid Hossain
Publié: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
par: Fred, Namanda Rogers
Publié: (2021)